Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data
Birkir Reynisson, Carolina Barra, Saghar Kaabinejadian, et al.
Journal of Proteome Research (2020) Vol. 19, Iss. 6, pp. 2304-2315
Open Access | Times Cited: 357

Showing 1-25 of 357 citing articles:

NetMHCpan-4.1 and NetMHCIIpan-4.0: improved predictions of MHC antigen presentation by concurrent motif deconvolution and integration of MS MHC eluted ligand data
Birkir Reynisson, Bruno Alvarez, Sinu Paul, et al.
Nucleic Acids Research (2020) Vol. 48, Iss. W1, pp. W449-W454
Open Access | Times Cited: 1508
Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
Eryn Blass, Patrick A. Ott
Nature Reviews Clinical Oncology (2021) Vol. 18, Iss. 4, pp. 215-229
Open Access | Times Cited: 721
Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial
Ben Creelan, Chao Wang, Jamie K. Teer, et al.
Nature Medicine (2021) Vol. 27, Iss. 8, pp. 1410-1418
Open Access | Times Cited: 288
An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study
Zikun Yang, Paul Bogdan, Shahin Nazarian
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 184
HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy
Ana Marcu, Leon Bichmann, Lèon Kuchenbecker, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 4, pp. e002071-e002071
Open Access | Times Cited: 174
Landscape of helper and regulatory antitumour CD4+ T cells in melanoma
Giacomo Oliveira, Kari Stromhaug, Nicoletta Cieri, et al.
Nature (2022) Vol. 605, Iss. 7910, pp. 532-538
Open Access | Times Cited: 121
Progress and challenges for the machine learning-based design of fit-for-purpose monoclonal antibodies
Rahmad Akbar, Habib Bashour, Puneet Rawat, et al.
mAbs (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 79
Machine learning for functional protein design
Pascal Notin, Nathan Rollins, Yarin Gal, et al.
Nature Biotechnology (2024) Vol. 42, Iss. 2, pp. 216-228
Closed Access | Times Cited: 75
In silico proof of principle of machine learning-based antibody design at unconstrained scale
Rahmad Akbar, Philippe A. Robert, Cédric R. Weber, et al.
mAbs (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 74
Peptide-Based Vaccines for Tuberculosis
Wenping Gong, Chao Pan, Peng Cheng, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 71
Peptide-binding specificity prediction using fine-tuned protein structure prediction networks
Amir Motmaen, Justas Dauparas, Minkyung Baek, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 9
Open Access | Times Cited: 70
Machine learning predictions of MHC-II specificities reveal alternative binding mode of class II epitopes
Julien Racle, Philippe Guillaume, Julien Schmidt, et al.
Immunity (2023) Vol. 56, Iss. 6, pp. 1359-1375.e13
Open Access | Times Cited: 60
Development and use of machine learning algorithms in vaccine target selection
Barbara Bravi
npj Vaccines (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 29
The genomic landscape of 2,023 colorectal cancers
Alex J. Cornish, Andreas Gruber, Ben Kinnersley, et al.
Nature (2024) Vol. 633, Iss. 8028, pp. 127-136
Open Access | Times Cited: 24
Immunopeptidomics-based identification of naturally presented non-canonical circRNA-derived peptides
Humberto J. Ferreira, Brian J. Stevenson, HuiSong Pak, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 16
Probiotic neoantigen delivery vectors for precision cancer immunotherapy
Andrew Redenti, Jongwon Im, Benjamin Redenti, et al.
Nature (2024) Vol. 635, Iss. 8038, pp. 453-461
Open Access | Times Cited: 16
Identification of indirect CD4+ T cell epitopes associated with transplant rejection provides a target for donor-specific tolerance induction
Zhuldyz Zhanzak, Aileen C. Johnson, P. S. Foster, et al.
Immunity (2025)
Closed Access | Times Cited: 2
Designing of an mRNA vaccine against high-risk human papillomavirus targeting the E6 and E7 oncoproteins exploiting immunoinformatics and dynamic simulation
Md. Mijanur Rahman, Md. Habib Ullah Masum, Rehana Parvin, et al.
PLoS ONE (2025) Vol. 20, Iss. 1, pp. e0313559-e0313559
Open Access | Times Cited: 1
Development of a novel multi-epitope subunit mRNA vaccine candidate to combat Acinetobacter baumannii
Shiyang Ma, Fei Zhu, Peipei Zhang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 1
Impact of genotypic variability of measles virus T-cell epitopes on vaccine-induced T-cell immunity
Maarten E. Emmelot, Rogier Bodewes, Cyril Maissan, et al.
npj Vaccines (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 1
SARS-CoV-2–specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein
Michael D. Keller, Katherine M. Harris, Mariah Jensen-Wachspress, et al.
Blood (2020) Vol. 136, Iss. 25, pp. 2905-2917
Open Access | Times Cited: 126
Design of a multi-epitope-based vaccine targeting M-protein of SARS-CoV2: an immunoinformatics approach
Vijaya Sai Ayyagari, T. C. Venkateswarulu, K. Abraham Peele, et al.
Journal of Biomolecular Structure and Dynamics (2020) Vol. 40, Iss. 7, pp. 2963-2977
Open Access | Times Cited: 92
Single-cell transcriptome and TCR profiling reveal activated and expanded T cell populations in Parkinson’s disease
Pingping Wang, Lifen Yao, Meng Luo, et al.
Cell Discovery (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 92
Dynamically evolving novel overlapping gene as a factor in the SARS-CoV-2 pandemic
Chase W. Nelson, Zachary Ardern, Tony L. Goldberg, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 88
Technological advances in cancer immunity: from immunogenomics to single-cell analysis and artificial intelligence
Ying Xu, Guan-Hua Su, Ding Ma, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 86
Page 1 - Next Page

Scroll to top